CEMATRIX Balance Sheet Health

Financial Health criteria checks 6/6

CEMATRIX has a total shareholder equity of CA$28.7M and total debt of CA$1.9M, which brings its debt-to-equity ratio to 6.7%. Its total assets and total liabilities are CA$39.3M and CA$10.6M respectively. CEMATRIX's EBIT is CA$2.4M making its interest coverage ratio 7.5. It has cash and short-term investments of CA$3.5M.

Key information

6.7%

Debt to equity ratio

CA$1.93m

Debt

Interest coverage ratio	7.5x
Cash	CA$3.49m
Equity	CA$28.72m
Total liabilities	CA$10.56m
Total assets	CA$39.28m

Recent financial health updates

Recent updates

A Piece Of The Puzzle Missing From CEMATRIX Corporation's (CVE:CVX) 26% Share Price Climb

Apr 24

CEMATRIX Corporation's (CVE:CVX) Subdued P/S Might Signal An Opportunity

Feb 06

Is CEMATRIX (CVE:CVX) Using Debt In A Risky Way?

Nov 10

CEMATRIX Corporation (CVE:CVX) Doing What It Can To Lift Shares

Jul 01

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Dec 15

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Aug 05

Is CEMATRIX (CVE:CVX) Weighed On By Its Debt Load?

Mar 21

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Dec 03

Calculating The Intrinsic Value Of CEMATRIX Corporation (CVE:CVX)

Jul 21

At CA$0.50, Is CEMATRIX Corporation (CVE:CVX) Worth Looking At Closely?

May 26

Here's Why CEMATRIX (CVE:CVX) Can Afford Some Debt

Mar 10

How Much Is CEMATRIX's (CVE:CVX) CEO Getting Paid?

Nov 25

Financial Position Analysis

Short Term Liabilities: CVX's short term assets (CA$17.9M) exceed its short term liabilities (CA$8.3M).

Long Term Liabilities: CVX's short term assets (CA$17.9M) exceed its long term liabilities (CA$2.2M).

Debt to Equity History and Analysis

Debt Level: CVX has more cash than its total debt.

Reducing Debt: CVX's debt to equity ratio has reduced from 216.1% to 6.7% over the past 5 years.

Debt Coverage: CVX's debt is well covered by operating cash flow (26.1%).

Interest Coverage: CVX's interest payments on its debt are well covered by EBIT (7.5x coverage).

CEMATRIX Balance Sheet Health

Financial Health criteria checks 6/6

Key information

Recent financial health updates

Is CEMATRIX (CVE:CVX) Using Debt In A Risky Way?

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Is CEMATRIX (CVE:CVX) Weighed On By Its Debt Load?

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Here's Why CEMATRIX (CVE:CVX) Can Afford Some Debt

Recent updates

Insufficient new directors

A Piece Of The Puzzle Missing From CEMATRIX Corporation's (CVE:CVX) 26% Share Price Climb

CEMATRIX Corporation, Annual General Meeting, Jun 24, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CEMATRIX Corporation to Report Q4, 2023 Results on Apr 10, 2024

CEMATRIX Corporation's (CVE:CVX) Subdued P/S Might Signal An Opportunity

CEMATRIX Corporation Appoints Marie-Josee Cantin as Chief Financial Officer

CEMATRIX Corporation Promotes Randy Boomhour to Chief Operating Officer, Effective January 1St, 2024

CEMATRIX Corporation Promotes Randy Boomhour to Chief Operating Officer, Effective January 1St, 2024

Third quarter 2023 earnings released: EPS: CA$0.014 (vs CA$0.004 loss in 3Q 2022)

Is CEMATRIX (CVE:CVX) Using Debt In A Risky Way?

CEMATRIX Corporation to Report Q3, 2023 Results on Nov 08, 2023

New major risk - Financial position

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.012 loss in 2Q 2022)

CEMATRIX Corporation to Report Q2, 2023 Results on Aug 09, 2023

CEMATRIX Corporation (CVE:CVX) Doing What It Can To Lift Shares

CEMATRIX Corporation to Report Q1, 2023 Results on May 10, 2023

Full year 2022 earnings released: CA$0.042 loss per share (vs CA$0.016 loss in FY 2021)

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Price target decreased to CA$0.80

Third quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.001 loss in 3Q 2021)

Second quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.004 loss in 2Q 2021)

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

First quarter 2022 earnings released: CA$0.017 loss per share (vs CA$0.003 profit in 1Q 2021)

Price target decreased to CA$1.00

CEMATRIX Corporation, Annual General Meeting, Jun 29, 2022

CEMATRIX Corporation Reports Impairment Charges for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings released: CA$0.016 loss per share (vs CA$0.16 loss in FY 2020)

Is CEMATRIX (CVE:CVX) Weighed On By Its Debt Load?

Is CEMATRIX (CVE:CVX) Using Too Much Debt?

Chief Financial Officer recently bought CA$124k worth of stock

Third quarter 2021 earnings released: CA$0.001 loss per share (vs CA$0.001 profit in 3Q 2020)

CEO, President & Director exercised options to buy CA$117k worth of stock.

CEO, President & Director recently sold CA$83k worth of stock

Second quarter 2021 earnings released: CA$0.004 loss per share (vs CA$0.01 loss in 2Q 2020)

Calculating The Intrinsic Value Of CEMATRIX Corporation (CVE:CVX)

VP of Sales & Marketing and GM recently sold CA$177k worth of stock

VP of Sales & Marketing and GM exercised options to buy CA$182k worth of stock.

At CA$0.50, Is CEMATRIX Corporation (CVE:CVX) Worth Looking At Closely?

VP of Sales & Marketing and GM recently sold CA$76k worth of stock

First quarter 2021 earnings released: EPS CA$0.003 (vs CA$0.023 loss in 1Q 2020)

Full year 2020 earnings released: CA$0.16 loss per share (vs CA$0.005 loss in FY 2019)

CEMATRIX Corporation has completed a Composite Units Offering in the amount of CAD 20 million.

Here's Why CEMATRIX (CVE:CVX) Can Afford Some Debt

New 90-day high: CA$0.85

New 90-day high: CA$0.57

Cematrix Corporation Announces Change of Chief Financial Officer

How Much Is CEMATRIX's (CVE:CVX) CEO Getting Paid?

Third quarter 2020 earnings released: EPS CA$0.001

New 90-day low: CA$0.40

New 90-day low - CA$0.42

Earnings released

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies